CD34 and coronary artery disorder: In this regard, Werner et al. demonstrated in 519 patients with coronary artery disease that increased numbers of CD34 + KDR+/105 WBC EPCs were associated with a reduced risk of death from cardiovascular causes and of recurrence of revascularization and hospitalization [24], a result recently confirmed by meta-analysis [25].